EDMONTON (CP) - ViRexx Medical Corp.'s 2004 loss more than doubled as the maker of treatments for cancer and chronic hepatitis B and C boosted spending on development and prepared to move a number of its drugs through clinical testing phases. ...More
Thursday, March 24, 2005
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment